Brian Farley to join Allscripts as General Counsel, Anita Pramoda and Michael Klayko Join Board of Directors
CHICAGO, May 24, 2013 /PRNewswire/ — Allscripts announced today important additions to the company’s senior leadership team and Board of Directors. Brian Farley will join the company as Senior Vice President, General Counsel and Corporate Secretary effective May 28, 2013. In addition, Allscripts added two new board members – Anita Pramoda and Michael Klayko – whose terms began May 21, 2013.
“All three individuals are highly-qualified professionals with outstanding experience,” said President and Chief Executive Officer Paul Black. “We know their contributions and insights will be instrumental in helping us realize our vision of a Connected Community of Health™.”
New SVP, General Counsel and Corporate Secretary
Farley brings more than 20 years of legal experience to Allscripts including most recently serving as General Counsel for Motorola Mobility’s Home Business. In this role, Farley managed all legal matters and operations for the nearly $3.5 billion operation, including issues related to manufacturing, sales, IP, litigation, and employment, culminating with Motorola Mobility and Google, Inc.’s recent $2.35 billion sale of the Home Business to ARRIS, Inc. Farley managed a 30-person global legal and public policy team with employees located on four continents.
During his nearly eight-year tenure at Motorola, Inc. and Motorola Mobility, Farley led multiple legal transactions, in addition to leading the global antitrust and regulatory approval process for the successful closing of the $12.5 billion sale of Motorola Mobility to Google in 2012.
Prior to becoming General Counsel of the Home Business, Farley was a member of the staff of Motorola Mobility’s president, and served as his primary legal counsel. He has served as lead attorney in negotiating and advising Motorola’s executive leadership teams on matters involving the separation of Motorola Mobility from the former Motorola, Inc., international joint ventures, restructuring deals, mergers, and other major transactions.
Farley holds a law degree from The George Washington University National Law Center, a Master’s of Business Administration from the University of Colorado and a Bachelor of Arts in International Political Economics from The Colorado College. Farley lives in the Chicago land area and will be based in Allscripts Chicago office.
New Board Members
Anita Pramoda and Michael Klayko have joined the Allscripts Board of Directors, adding to its six existing members.
Anita Pramoda was recently the Chief Financial Officer of Epic Systems Corporation. Pramoda led Epic through a period of significant domestic market growth, its expansion into the governmental and international markets, and its launch into mobile health IT solutions.
Prior to Epic, Pramoda helped commercialize self-healing packaging technology into wholesale, retail, and military sectors at Ontech.
Pramoda is the co-founder of TangramCare, a technology-enabled care delivery system that affords extremely sick patients an opportunity to receive care in their homes, recover comfortably, and convalesce with dignity. She is also an executive advisor at Technology Crossover Ventures, a leading VC firm. Pramoda holds a Bachelor of Science degree in Engineering and an MBA from The Wharton School, University of Pennsylvania.
Michael Klayko joins Allscripts from Brocade Communications where he served as CEO from 2005 until January 2013. Under his leadership, revenue grew from $525 million to $2.3 billion while profit increased from $3 million to $570 million. Klayko joined Brocade in 2003 as CEO following the acquisition of Rhapsody Networks in March 2003, where he was also the CEO the prior two years.
Klayko also served in numerous other senior leadership roles throughout his career, including Executive Vice President of Sales & Marketing for McData Corporation, and Senior Vice President of Sales for EMC Corporation. Klayko began his career at IBM where he spent a decade of his career performing multiple assignments and management roles.
Klayko received his Bachelor of Electronic Engineering from the Ohio Institute of Technology. He also completed an Entrepreneurial Executive Education Program at Babson College, a certification in Public Board education at UCLA‘s Anderson School of Business, and a Public Board education for Corporate Governance from Stanford Law School.
Allscripts (NASDAQ: MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company’s Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a Connected Community of Health™ for physicians, hospitals and post-acute organizations. To learn more about Allscripts, please visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2013 Allscripts Healthcare, LLC. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are either registered trademarks or trademarks of Allscripts Healthcare, LLC in the United States and/or other countries. All other trademarks are the property of their respective owners.
This press release contains forward-looking statements within the meaning of the federal securities laws. Statements regarding future events or developments, our future performance, as well as management’s expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements with the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on our results of operations or financial condition. Such risks, uncertainties and other factors include, among other things: the possibility that the expected synergies, efficiencies and cost savings of the merger with Eclipsys Corporation (“Eclipsys”) will not be realized, or will not be realized within the expected time period; potential difficulties or delays in achieving platform and product integration and the connection and movement of data among hospitals, physicians, patients and others; the risk that the Allscripts and Eclipsys businesses will not be integrated successfully; competition within the industries in which we operate; failure to achieve certification under the Health Information Technology for Economic and Clinical Health Act could result in increased development costs, a breach of some customer obligations and could put us at a competitive disadvantage in the marketplace; the volume and timing of systems sales and installations, the length of sales cycles and the installation process and the possibility that our products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; the outcome of any legal proceeding that has been or may be instituted against us; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry, including possible regulation of our software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; the implementation and speed of acceptance of the electronic record provisions of the American Recovery and Reinvestment Act of 2009; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers and our ability to obtain, use or successfully integrate third-party licensed technology; and breach of our security by third parties. See our Annual Report on Form 10-K for 2011 and other public filings with the SEC for a further discussion of these and other risks and uncertainties applicable to our business. The statements herein speak only as of their date and we undertake no duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations.
SOURCE Allscripts Healthcare Solutions, Inc.
Investors, Seth Frank, 312-506-1213, firstname.lastname@example.org, or Media: Claire Weingarden, 312-447-2442, email@example.com